ARTICLE | Clinical News
Squalamine synthetic aminosterol small molecule regulatory update
November 20, 2000 8:00 AM UTC
MAGN received U.S. Patent No. 6,147,060 covering the use of its squalamine angiogenesis inhibitor to treat cancer. The product is in Phase II testing to treat non-small cell lung cancer (NSCLC) and ov...